Health Care CEO Hit With Novel Insider Trading Indictment

By Jessica Corso · March 1, 2023, 5:07 PM EST

Federal prosecutors in California announced Wednesday that they've filed the first ever criminal case based exclusively on an executive's use of so-called Rule 10b5-1 trading plans, accusing the CEO of a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Securities and Exchange Commission v. Teren S. Peizer et al

Case Number

Court

California Central

Nature of Suit

Securities/Commodities

Date Filed

March 01, 2023

Recent Articles By Jessica

May 16, 2024
3rd Circ. Shuns Teva's 'Novel' Appeal On Israeli Investor Class
March 25, 2024
COVID 'Cure' Claims Can't Sustain Fraud Suit, 9th Circ. Rules
March 08, 2024
Judge Keeps Novel Insider Trading Indictment Alive
October 04, 2023
Justices Urged To Halt All In-House Cases Until Congress Acts
September 26, 2023
Accounting Board Fines BDO $2M Over Missed Red Flags
June 29, 2023
Pfizer Insider Charged With Profiting Off COVID Drug Info
May 02, 2023
High Court Whistleblower Case Is Bigger Than Wall Street
April 20, 2023
Feds Say Justices Should Reject Appeal From Ex-Shkreli Atty
March 08, 2023
AmEx Could Face Shareholder Vote On Abortion Ban Risks
March 06, 2023
DOJ Cautions Execs With Novel Insider Trading Case